Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer

BACKGROUND: Urothelial bladder cancer is the ninth most common cancer. Despite surgical and chemotherapeutic treatment the prognosis is still poor once bladder cancer progresses to a muscle-invasive state. Discovery of new diagnostic markers and pathophysiologic effectors might help to contribute to...

Descripción completa

Detalles Bibliográficos
Autores principales: Niedworok, Christian, Röck, Katharina, Kretschmer, Inga, Freudenberger, Till, Nagy, Nadine, Szarvas, Tibor, vom Dorp, Frank, Reis, Henning, Rübben, Herbert, Fischer, Jens W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819308/
https://www.ncbi.nlm.nih.gov/pubmed/24223213
http://dx.doi.org/10.1371/journal.pone.0080084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819308/
https://www.ncbi.nlm.nih.gov/pubmed/24223213
http://dx.doi.org/10.1371/journal.pone.0080084

Ejemplares similares